Valuation Conexeu Sciences Inc.

Stocks

Market Closed - Nasdaq 23:00:00 28/10/2026 +03			5-day change	1st Jan Change
2.880 ^USD	-2.37%		-13.51%	-

10-16	Conexeu Sciences Closes $5 Million Private Placement	MT
10-15	Conexeu Sciences Inc. announced that it has received $5 million in funding	CI

Data adjusted to current consolidation scope

Fiscal Period: October	2026	2027	2028
Market Cap ¹	88.8	-	-
Change	-	-	-
Enterprise Value (EV)	88.8	88.8	88.8
Change	-	0%	0%
P/E	-7.2x	-5.43x	2.82x
PBR	-	-	-
PEG	-0.2x	-0.2x	-0x
Capitalization / Revenue	-	-	0.63x
EV / Revenue	-	-	0.63x
EV / EBITDA	-	-	-
EV / EBIT	-9.26x	-6.01x	2.19x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-0.4	-0.53	1.02
Distribution rate	-	-	-
Net sales ¹	-	-	140.2
EBITDA	-	-	-
EBIT ¹	-9.592	-14.78	40.51
Net income ¹	-9.512	-14.78	37.92
Net Debt	-	-	-
Reference price ²	2.880	2.880	2.880
Nbr of stocks (in thousands)	30,832	-	-
Announcement Date	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CONEXEU SCIENCES INC.	-7.2x	-	-	-	88.8M
WUXI APPTEC CO., LTD.	16.92x	6.39x	12.26x	1.77%	64.14B
ARGENX SE	30.57x	8.11x	26.59x	0.05%	55.53B
LONZA GROUP AG	36.68x	6.52x	19.45x	0.88%	53.03B
IQVIA HOLDINGS INC.	35.39x	3.41x	14.74x	-.--%	45.99B
BEONE MEDICINES AG	49.25x	5.68x	31.09x	-.--%	42.45B
REVOLUTION MEDICINES, INC.	-19.59x	189.6x	-20.86x	-.--%	40.45B
CELLTRION, INC.	31.7x	8.06x	20.96x	0.41%	32.25B
GENMAB A/S	47.12x	8.37x	28.08x	-.--%	34.47B
WUXI BIOLOGICS (CAYMAN) INC.	27.96x	5.9x	15.29x	-.--%	24.23B
Average	24.88x	26.89x	16.40x	0.34%	39.26B
Weighted average by Cap.	27.96x	25.38x	16.46x	0.45%